Clinical and molecular implications of antipsychotics in MASLD

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), has emerged as a major comorbidity among patients with severe mental illness (SMI), particularly those treated with second-generation antipsychotics (SGAs). These agents ind...

全面介紹

書目詳細資料

Principais autores:	Celina Gonzalez-Peña, Misael Uribe, Norberto C. Chavez-Tapia
格式:	Artigo
語言:	Inglês
出版:	Elsevier 2026-07-01
叢編:	Annals of Hepatology
主題:	MASLD Antipsychotics Olanzapine Clozapine Risperidone Mitochondrial dysfunction
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S1665268125003837
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!